Literature DB >> 8821312

The effect of sequential antidepressant treatment on geriatric depression.

A J Flint1, S L Rifat.   

Abstract

This study evaluated the outcome of elderly depressed patients who were refractory to, or intolerant of, an initial trial of nortriptyline and who then underwent systematic treatment with other antidepressant therapies. 101 patients entered the study and 61% responded to nortriptyline, 64% of patients who did not improve with nortriptyline eventually responded to other antidepressant treatments. Response to second-line treatment (phenelzine) was significantly slower than response to the tricyclic antidepressant. Treatment nonresponders were more likely to have a longer episode length at index assessment and higher baseline anxiety scores compared with responders. This study demonstrates the importance of persisting with systematic antidepressant therapy in elderly patients who do not respond to the first trial of treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8821312     DOI: 10.1016/0165-0327(95)00063-1

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

1.  Antidepressants for old people. GPs should become familiar with one or two antidepressants from each class.

Authors:  R C Baldwin
Journal:  BMJ       Date:  1999-09-25

Review 2.  Pharmacologic treatment of depression in late life.

Authors:  A J Flint
Journal:  CMAJ       Date:  1997-10-15       Impact factor: 8.262

Review 3.  Use of antidepressants in late-life depression.

Authors:  Tarek K Rajji; Benoit H Mulsant; Francis E Lotrich; Cynthia Lokker; Charles F Reynolds
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age.

Authors:  Henry C Driscoll; Jordan F Karp; Mary Amanda Dew; Charles F Reynolds
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 5.  Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents.

Authors:  A J Flint
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

Review 6.  Going beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: a critical review.

Authors:  Donovan T Maust; David W Oslin; Michael E Thase
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

7.  Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.

Authors:  Jordan F Karp; Ellen M Whyte; Eric J Lenze; Mary A Dew; Amy Begley; Mark D Miller; Charles F Reynolds
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

Review 8.  Treatment-resistant Late-life Depression: Challenges and Perspectives.

Authors:  Christian Knöchel; Gilberto Alves; Benedikt Friedrichs; Barbara Schneider; Anna Schmidt-Rechau; Sofia Wenzler; Angelina Schneider; David Prvulovic; André F Carvalho; Viola Oertel-Knöchel
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

9.  How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.

Authors:  Mazda Adli; Katja Wiethoff; Thomas C Baghai; Robert Fisher; Florian Seemüller; Gregor Laakmann; Peter Brieger; Joachim Cordes; Jaroslav Malevani; Gerd Laux; Iris Hauth; Hans-Jürgen Möller; Klaus-Thomas Kronmüller; Michael N Smolka; Peter Schlattmann; Maximilian Berger; Roland Ricken; Thomas J Stamm; Andreas Heinz; Michael Bauer
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

Review 10.  Monoamine oxidase inhibitors. A perspective on their use in the elderly.

Authors:  H P Volz; C H Gleiter
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 4.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.